NAMS NewAmsterdam Pharma Company NV Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NAMS
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NAMS
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 19.83% to -49 cents per share on November 11

NewAmsterdam Pharma Company NV NAMS Stock Earnings Reports

Q3'24

Est.

$-0.49

Q2'24

Beat

by $0.17

Q1'24

Missed

by $0.44

Q4'23

Beat

by $0.04

Q3'23

Beat

by $0.31

The last earnings report on August 07 showed earnings per share of -40 cents, beating the estimate of -57 cents. With 129.20K shares outstanding, the current market capitalization sits at 1.46B.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Gooimeer 2-35

Phone

+31 352062971

Employees

Web

https://www.newamsterdampharma.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

NAMS and Stocks

Correlation & Price change

A.I.dvisor tells us that NAMS and GYRE have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NAMS and GYRE's prices will move in lockstep.

Ticker / NAME	Correlation To NAMS	1D Price Change %
NAMS	100%	-3.11%
GYRE - NAMS	29% Poorly correlated	-11.26%
RVMD - NAMS	25% Poorly correlated	-2.51%
SANA - NAMS	24% Poorly correlated	-7.44%
SNDX - NAMS	24% Poorly correlated	-0.05%
VERV - NAMS	22% Poorly correlated	-9.25%
More